RYTM - Rhythm Pharmaceuticals Inc.
IEX Last Trade
47.39
1.290 2.722%
Share volume: 247,081
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$46.10
1.29
2.80%
Summary score
25%
Profitability
25%
Dept financing
12%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-29.89%
Return on assets
-16.2%
Return on sales
-9781.63%
Return on invested capital
315.79%
Total debt ratio
26.36%
Debt ratio change over timeo
-0.9%
Current Ratio
10.45%
Quick Ratio
10.03%
Cash Position Ratio
9.25%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-75.52%
Return on assets
-23.48%
Return on sales
-286.7%
Return on invested capital
249.1%
Total debt ratio
52.65%
Debt ratio change over timeo
-0.74%
Current Ratio
5.66%
Quick Ratio
5.51%
Cash Position Ratio
5.05%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-229.57%
Return on assets
-54.08%
Return on sales
-538.71%
Return on invested capital
452.22%
Total debt ratio
76.19%
Debt ratio change over time
-0.44%
Current Ratio
4.35%
Quick Ratio
4.2%
Cash Position Ratio
3.71%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-115.16%
Return on assets
-106.09%
Return on sales
-2247.78%
Return on invested capital
16.41%
Total debt ratio
-89.7%
Debt ratio change over time
-0.9%
Current Ratio
1.96%
Quick Ratio
1.76%
Cash Position Ratio
1.55%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RYTM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -29.89% | 13.79% | 34.47% | 7.43% |
| Return on assets | -16.2% | 2.76% | 3.15% | 5.62% |
| Return on sales | -9781.63% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 315.79% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 57% |
| Total debt ratio | 26.36% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.9% | 308.97% | -6.99% | 1.18% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 5.66% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.51% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.05% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 11% | 26% |
| Short-term ratios | RYTM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -75.52% | 13.77% | 13.25% | 3.8% |
| Return on assets | -23.48% | 2.43% | 1.89% | 3.09% |
| Return on sales | -286.7% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 249.1% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 52.65% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.74% | 46.38% | -72.08% | 1.51% |
| Dept financing | 14% | 50% | 25% | 7% |
| Current Ratio | 5.66% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.51% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.05% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 24% | 59% |